Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.190
+0.030 (2.59%)
At close: Jan 21, 2025, 4:00 PM
1.150
-0.040 (-3.36%)
After-hours: Jan 21, 2025, 7:59 PM EST
Alzamend Neuro Employees
As of April 30, 2024, Alzamend Neuro had 7 total employees, including 4 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$843,367
Market Cap
6.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ALZN News
- 5 months ago - Alzamend Neuro Stock Jumps After Post Traumatic Stress Disorder Study Pact: Details - Benzinga
- 5 months ago - Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder - Business Wire
- 9 months ago - Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program - Business Wire
- 1 year ago - Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's - Business Wire
- 1 year ago - Ault Alliance Announces Alzamend Neuro Has Initiated Its Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer's Type - Business Wire
- 2 years ago - BitNile Holdings Contemplates Exchange Offer to Acquire Shares of Its Common Stock - Business Wire
- 2 years ago - In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Stephan Jackman, CEO Alzamend Neuro, Inc. - Accesswire
- 2 years ago - BitNile Holdings Reports Third Quarter 2022 Financial Results, Including Revenue of $100 Million for the Nine Months Ended September 30, 2022, up 124% from the Prior Year's Nine-Month Period - Business Wire